Grail (NASDAQ:GRAL) Sees Large Volume Increase – What’s Next?

Grail, Inc. (NASDAQ:GRALGet Free Report) saw unusually-strong trading volume on Tuesday . Approximately 945,734 shares changed hands during trading, a decline of 26% from the previous session’s volume of 1,280,710 shares.The stock last traded at $61.89 and had previously closed at $55.02.

Analyst Ratings Changes

A number of research firms recently issued reports on GRAL. Morgan Stanley began coverage on shares of Grail in a report on Wednesday, November 27th. They issued an “equal weight” rating and a $16.00 price objective on the stock. Wolfe Research began coverage on shares of Grail in a report on Friday, November 15th. They issued a “peer perform” rating on the stock.

Check Out Our Latest Report on GRAL

Grail Stock Down 9.2 %

The business’s fifty day moving average is $26.32 and its 200-day moving average is $19.06.

Grail (NASDAQ:GRALGet Free Report) last issued its quarterly earnings results on Thursday, February 20th. The company reported ($1.86) earnings per share for the quarter, beating the consensus estimate of ($4.41) by $2.55. As a group, analysts expect that Grail, Inc. will post -65.16 EPS for the current year.

Hedge Funds Weigh In On Grail

Large investors have recently added to or reduced their stakes in the company. FNY Investment Advisers LLC purchased a new position in Grail during the fourth quarter valued at approximately $26,000. State of Tennessee Department of Treasury bought a new stake in shares of Grail during the fourth quarter valued at approximately $28,000. Lindbrook Capital LLC bought a new stake in shares of Grail during the fourth quarter valued at approximately $28,000. Sterling Capital Management LLC bought a new stake in shares of Grail during the fourth quarter valued at approximately $29,000. Finally, Wellington Shields Capital Management LLC bought a new stake in shares of Grail during the fourth quarter valued at approximately $33,000.

Grail Company Profile

(Get Free Report)

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.

See Also

Receive News & Ratings for Grail Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Grail and related companies with MarketBeat.com's FREE daily email newsletter.